Schrödinger partners with Lilly to unlock $1B AI "TuneLab" for biotechs
Schrödinger (NASDAQ:SGDR) announced a strategic collaboration with Eli Lilly and Company (NYSE:LLY) on Friday to integrate Lilly’s high-powered TuneLab™ AI platform directly into Schrödinger’s flagship enterprise software, LiveDesign.









%2520inhalation%2520powder-640x640.png&w=3840&q=75)

